Author:
Nordlund Marianne S.,Stieber Petra,Brustugun Odd Terje,Warren David J.,Paus Elisabeth
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Jorgensen LG, Osterlind K, Hansen HH, Cooper EH. Serum neuron-specific enolase (S-NSE) in progressive small-cell lung cancer (SCLC). Br J Cancer. 1994;70:759–61.
2. Jorgensen LG, Osterlind K, Genolla J, Gomm SA, Hernandez JR, Johnson PW, et al. Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres. Br J Cancer. 1996;74:463–7.
3. Molina R, Auge JM, Filella X, Vinolas N, Alicarte J, Domingo JM, et al. Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer. Anticancer Res. 2005;25:1773–8.
4. Niho S, Nishiwaki Y, Goto K, Ohmatsu H, Matsumoto T, Hojo F, et al. Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung cancer: comparative evaluation with neuron-specific enolase and carcinoembryonic antigen. Lung Cancer. 2000;27:159–67.
5. Stieber P, Dienemann H, Schalhorn A, Schmitt UM, Reinmiedl J, Hofmann K, et al. Pro-gastrin-releasing peptide (ProGRP)—a useful marker in small cell lung carcinomas. Anticancer Res. 1999;19:2673–8.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献